OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The improvement of recombinant antibody production in Chinese Hamster Ovary (CHO) cells is a crucial aspect of biopharmaceutical development. To maximize yield, various methods are employed, including genetic engineering of the host cells and optimization of growth conditions. Furthermore, implementation of advanced bioreactors can significantly